Atlas Trials

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Clinical trial NCT01568216 · TERMINATED

Trial details

NCT number
NCT01568216
Sponsor
Amgen
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2012-05-01
Primary completion
2013-06-01
Enrollment
121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.